Document Detail


The diagnosis and treatment of hypertensive crises.
MedLine Citation:
PMID:  19179809     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hypertension (HTN) is one of the most common chronic medical conditions, affecting nearly 72 million people in the United States. A systolic blood pressure (BP) > 180 mm Hg or a diastolic BP > 120 mm Hg is considered a "hypertensive crisis." Hypertensive crises are categorized as either hypertensive emergencies or urgencies depending on the degree of BP elevation and presence of end-organ damage. The primary goal of intervention in a hypertensive crisis is to safely reduce BP. Immediate reduction in BP is required only in patients with acute end-organ damage (ie, hypertensive emergency). This requires treatment with a titratable shortacting intravenous (IV) antihypertensive agent, while severe HTN with no acute end-organ damage (ie, hypertensive urgency) is usually treated with oral antihypertensive agents. Patients with hypertensive emergencies are best treated in an intensive care unit (ICU) with titratable IV hypotensive agents. Rapid-acting IV antihypertensive agents are available, including clevidipine, labetalol, esmolol, fenoldopam, nicardipine, and sodium nitroprusside. Newer agents such as clevidipine have considerable advantages compared with other available agents in the management of hypertensive crises. Sodium nitroprusside is an extremely toxic drug, and its use in the treatment of hypertensive emergencies should be avoided. Likewise, nifedipine, nitroglycerin, and hydralazine should not to be considered first-line therapies in the management of hypertensive crises because these agents are associated with significant toxicities and/or side effects.
Authors:
Joseph Varon
Related Documents :
15462109 - Should the preservation of residual renal function cost volume overload and its consequ...
20652659 - Urapidil, a dual-acting antihypertensive agent: current usage considerations.
19695029 - A home blood pressure monitor equipped with a graphic function facilitates faster blood...
20409919 - Effects of metoprolol succinate extended release vs. amlodipine besylate on the blood p...
9228929 - Effect of nitroglycerin and cerebrospinal fluid drainage on spinal cord perfusion press...
15839719 - Hypertension in the elderly: a japanese perspective.
24326719 - A patient with low pressure idiopathic intracranial hypertension and multiple cranial n...
8694309 - The effects of varying volumes of crystalloid administration before cesarean delivery o...
19602329 - Hypertension, dementia, and antihypertensive treatment: implications for the very elderly.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Postgraduate medicine     Volume:  121     ISSN:  1941-9260     ISO Abbreviation:  Postgrad Med     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-01-30     Completed Date:  2009-02-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401147     Medline TA:  Postgrad Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5-13     Citation Subset:  AIM; IM    
Affiliation:
The University of Texas Health Science Center at Houston, Houston, TX, USA. joseph.varon@uth.tmc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / administration & dosage,  adverse effects,  therapeutic use*
Blood Pressure*
Female
Humans
Hypertension / classification,  diagnosis*,  drug therapy*
Male
Severity of Illness Index
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The protective effect of a newly developed molecular chaperone-inducer against mouse ischemic acute ...
Next Document:  Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?